Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Leukemia
Bolli, Niccolo N; Biancon, Giulia G; Moarii, Matahi M; Gimondi, Silvia S; Li, Yilong Y; de Philippis, Chiara C; Maura, Francesco F; Sathiaseelan, Vijitha V; Tai, Yu-Tzu YT; Mudie, Laura L; O'Meara, Sarah S; Raine, Keiran K; Teague, Jon W JW; Butler, Adam P AP; Carniti, Cristiana C; Gerstung, Moritz M; Bagratuni, Tina T; Kastritis, Efstathios E; Dimopoulos, Meletios M; Corradini, Paolo P; Anderson, Kenneth C KC; Moreau, Philippe P; Minvielle, Stephane S; Campbell, Peter J PJ; Papaemmanuil, Elli E; Avet-Loiseau, Herve H; Munshi, Nikhil C NC
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
Cancer Discovery
Hong, David S DS; Morris, Van K VK; El Osta, Badi B; Sorokin, Alexey V AV; Janku, Filip F; Fu, Siqing S; Overman, Michael J MJ; Piha-Paul, Sarina S; Subbiah, Vivek V; Kee, Bryan B; Tsimberidou, Apostolia M AM; Fogelman, David D; Bellido, Jorge J; Shureiqi, Imad I; Huang, Helen H; Atkins, Johnique J; Tarcic, Gabi G; Sommer, Nicolas N; Lanman, Richard R; Meric-Bernstam, Funda F; Kopetz, Scott S